ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesND BioSciences SA
ND BioSciences SA Logo
Verified· 4 sourcesTrust Score
Summary

About the company

ND BioSciences SA develops next-generation therapeutics and diagnostic assays for neurodegenerative diseases using validated and patented protein‑engineering and cellular drug‑discovery platforms. The company, a spin-off from the École polytechnique fédérale de Lausanne (EPFL), applies models that reproduce pathogenic protein aggregates and aggregation stages to support drug and biomarker development.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.7/5

ND BioSciences SA

✓ Offered5
Platforms for protein engineering and drug discovery
Platforms for chemical protein synthesis and reproduction of pathological protein forms for drug and biomarker discovery in neurodegenerative diseases, including α-synuclein, Tau, Huntingtin and TDP43.
Therapeutic development programmes for neurodegenerative diseases
Development of therapies and combination therapies for neurodegenerative diseases, focusing on inhibition of aggregation, clearance of existing aggregates, and blocking uptake and spread of pathological aggregates.
Research platforms for preclinical models
Cell-free, cellular, neuronal and animal models for analyzing protein aggregation kinetics, toxicity, Lewy body formation, mechanism of action and efficacy of potential therapeutic molecules.
Biomarker discovery for neurodegenerative diseases
Development of relevant targets and assays for biomarker discovery, early diagnosis and monitoring of disease progression in Parkinson, Alzheimer and Huntington.
Research partnerships
Collaborations with external partners to provide synuclein protein proteoforms, to accelerate assays and to develop diagnostics and therapeutics.
Trust & reputation

ranQ Trust Score of ND BioSciences SA: 3.7 out of 5.0

Trust Score3.7/ 5.0

Solid

x

Data basis 100% · As of October 2026

ND BioSciences SA scores 49.8 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.68.224%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.17.610%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.35.08%
ND BioSciences SA scores 74.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
ND BioSciences SA scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
ND BioSciences SA scores 12.2 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.14.34%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

ND BioSciences SA reaches a ranQ Trust Score of 3.7 out of 5.0 — rated «Solid». The rating draws, among other things, on 5.0 out of 5 stars from 1 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

February 14, 2020Media
Award winning ND BioSciences joins StartLab
startupticker.ch

Knowledge

No knowledge articles yet

Once ND BioSciences SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

ND BioSciences SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank ND BioSciences SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of ND BioSciences SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 5
1066 Epalinges
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-197.994.328
Founded
2019 · 7 years
Last commercial register change
March 26, 2019
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ST
    Synameta Therapeutics SARL
    Epalinges
    ES
    Exciva Switzerland SA
    Epalinges
    OB
    Opna Bio Switzerland Sàrl
    Epalinges
    AT
    ADC Therapeutics SA
    Epalinges
    NS
    Novassay SA
    Epalinges
    VS
    VivoArchitect Sàrl
    Epalinges
    AI
    AC Immune SA
    Lausanne
    BT
    Biodelphis Therapeutics SA
    Lausanne